While the BBC airs primetime documentaries screaming about Lover, Liar, Predator and Al Fayed: Predator at Harrods — hunting men who abused power for sexual control — it simultaneously runs puff pieces celebrating the government paying family doctors £3,000 annual cash bonuses (plus £1,000 for every referral) to push Eli Lilly’s Mounjaro (tirzepatide) weight-loss jabs.
The BBC isn’t hunting predators anymore; it’s providing the camouflage for them.
The predator isn’t hiding in the shadows anymore. It’s wearing a white coat, funded by your taxes, holding a government syringe, and clutching a blood-stained wad of corporate bribes.
In 2026, you aren’t a patient; you are depreciating biological capital. Your body has been leased to Eli Lilly under a biometric rent-trap. The drug is the firmware update, the GP is the technician installing it, and BlackRock is the landlord collecting the monthly subscription fee — paid by taxpayers — while you remain macroeconomically serviceable until end of life.
Under the 2026/27 GP contract, practices earn up to £3,000 a year for hitting “maximum number” targets on Mounjaro prescriptions — plus £1,000 per referral. Ring-fenced pot: £25 million. This is the first time the NHS has ever tied direct financial incentives in the core GP contract to one specific brand-name drug.
These payments are hard-coded into the Quality and Outcomes Framework (QOF) — the national pay-for-performance system that tracks and rewards GPs like lines of code in a transaction processor.
When a GP clicks ‘Yes’ on OB005 — the clinical euphemism for prescribing the jab — it’s not a consultation; it’s a transaction. Your BMI and compliance become a bounty-hunting ledger entry. The government demonises “rogue private prescribers” while turning every GP practice into the biggest quota-driven distributor of all.
Eligibility? Still brutally narrow: BMI ≥40 (or 37.5 for some ethnic groups) plus multiple comorbidities. Later widening to BMI 35+ is years away and capped at ~220,000 patients by 2028. Meanwhile, 9 in 10 current users pay privately. The bonuses don’t widen access — they just force GPs to process the tiny eligible pool faster while creating a quota system.
Wes Streeting calls it a “game changer” for “prevention.”
Keir Starmer says the drugs will “boost the UK economy” by fixing “worklessness.”
Translation: Your body is now human infrastructure to be chemically recalibrated for State productivity. Obese and on benefits? Here’s your jab so you can work harder and cost the state less.
The British Medical Association and Royal College of GPs are apoplectic.
Dr Katie Bramall (BMA): “These proposals will do nothing over the next year to address the divide between those able to pay and those left waiting.”
Prof Victoria Tzortziou Brown (RCGP): “GPs do not withhold treatment or prescribe based on financial incentives… Widening the roll-out could end up increasing workload in a way that may not be sustainable and risk raising unrealistic expectations among patients who may not be eligible.”
Katharine Jenner (Obesity Health Alliance): The drugs need “sustained support” — support the £3,000 clinical kickback does not fund.
GPs are being downgraded from clinicians to biological mechanics — paid bounties to install Eli Lilly’s chemical firmware into the economically inactive.
Wes Streeting has pocketed £372,000 since 2015 from donors linked to private healthcare and life sciences — roughly 60% of his total donations.
John Armitage (hedge fund Egerton Capital): £95,000 to Streeting. His firm holds $216 million+ (£169m) in Eli Lilly shares — the maker of the very drug now getting GP bounties.
OPD Group / MPM Connect (Peter Hearn — NHS/private recruitment): £197,900+ total, including £53,000 in Feb 2025 “for staffing costs in Streeting’s office.”
Doctors’ Association UK, We Own It, and EveryDoctor have issued open letters demanding Streeting release all WhatsApp messages with these top donors. The public smells quid pro quo.
This wasn’t Starmer’s bright idea. The Tony Blair Institute (TBI) — led by WEF Board of Trustees member Tony Blair — wrote the blueprint.
In its May 2025 report Anti-Obesity Medications: Faster, Broader Access Can Drive Health and Wealth in the UK, TBI doesn’t talk about “health.” It talks about serviceable biological capital. Obesity is a “macroeconomic burden” costing £98 billion annually, with two-thirds hitting people directly and the rest via welfare, lost productivity, and NHS costs. Their modelling targets “underperforming assets” in their 40s–60s for chemical recalibration to slash “worklessness” and deliver £52 billion cumulative fiscal benefits by 2050 through a nationwide preventative programme called “Protect Britain”.
Starmer and Streeting simply executed the Blairite memo. The 2026/27 GP contract and QOF codes OB004/OB005 are the delivery mechanism.
The NHS has been inverted. Once a public, national service dedicated to the health of British citizens, it is now a top-down, private corporate global utility engineered for workforce productivity and GDP extraction.
The ‘National’ in NHS is now pure branding. Local GP clinical judgment has been replaced by global strategic partnerships. Keir Starmer’s £279m deal with Eli Lilly wasn’t domestic policy — it was a strategic collaboration launched at an international investment summit. NHS England’s seminars with the World Health Organization under the “Working for Health 2030” programme confirm the goal: standardise this productivity model worldwide.
https://www.weforum.org/organizations/nhs-england/
Decisions are no longer made in a consultation room. They are triggered by QOF code OB005 and processed by Palantir’s Federated Data Platform. While the NHS Constitution still claims to be ‘public,’ the reality is a black-box algorithmic gaze where a WEF-linked US spy-tech firm holds the keys to 65 million biological capital records.
You are no longer a citizen with a right to care — you are depreciating biological capital that requires chemical overhaul to remain macroeconomically serviceable.
October 2024: Keir Starmer personally launches a £279 million Eli Lilly “strategic collaboration”.
August 2025: Another £85 million joint obesity programme (£35 million direct from Lilly).
Late 2025: Eli Lilly hikes the private UK price of Mounjaro by up to 170%. NHS price protected.
This wasn’t charity. It was a down-payment on British endocrine systems — the start of endocrine sharecropping.
Dramatic loss, then rebound the moment you stop. Lifelong dependency, GI hell. Clinical data and FDA/MHRA official labels list the following 'management' costs: pancreatitis, gallstones, hair loss, and sarcopenia (muscle wasting)—the hollowed-out 'Ozempic face' of a population inverted into serviceable biological capital.
BlackRock (~7-8%) and Vanguard (~9%) are top owners of Eli Lilly (and Pfizer, AstraZeneca, Novo Nordisk). They don’t want cures. They want recurring revenue — a state-funded biometric rent-trap where the software is tirzepatide and the hardware is your body.
In October 2025, Bill Gates and PAHO/WHO announced plans to make these drugs “super, super cheap” for lower-income countries—standardising pharmaceutical dependency globally under a high-volume, state-subsidised procurement model.
This isn’t just a health initiative. This is the Biometric Tether — Digital ID by stealth.
Palantir didn’t arrive with COVID. In July 2019 — months before the first UK case — Palantir executives hosted NHS England chair David Prior for dinner and watermelon cocktails, then demos in San Francisco and at Davos, explicitly pitching access to the “crown jewels”: 65 million patient records.
The pandemic gave the perfect ‘emergency’ Trojan horse. In March 2020, Palantir secured a £1 trial contract for the NHS COVID-19 Data Store — the largest single pool of patient data in UK history. That foothold became the £23.5m extension, then the full £330-480 million Federated Data Platform (FDP) now being forced on every trust.
The broker? Deviant Peter Mandelson — arrested on 23 February 2026 on suspicion of misconduct in public office. DOJ-released Epstein files show Mandelson forwarding sensitive 2009 government documents to Epstein while Business Secretary. As Ambassador and via his lobbying firm Global Counsel (on Palantir’s payroll), Mandelson facilitated Keir Starmer’s February 2025 visit to Palantir HQ — paving the way for the record contracts.
Under the FDP, your BMI isn’t just health data — it’s a productivity metric in Palantir’s algorithmic gaze. Link it to QOF OB005 prescription compliance and employment status, and you have a Biological Social Credit System. The NHS App becomes your de facto Digital ID: up-to-date on pharmaceutical firmware = serviceable worker. Stop the jab? Rebound flags a non-compliance event. Your status turns red.
They don’t need a microchip when they have a monthly prescription. This is not a diet. It’s a Digital Leash.
Manufacturers (Chemical Landlords)
Eli Lilly (Mounjaro) + GP bounties
Owners & Architects (The Money & Blueprints)
BlackRock & Vanguard – ultimate shareholders
Tony Blair Institute – scripted “Protect Britain” and QOF takeover
NICE – under lobbying to prioritise macroeconomic growth
Bill Gates Foundation – globalising the model
Enforcers & Brokers (Political & Administrative)
Wes Streeting – £372,000 donor-funded Health Secretary
NHS England – writes the bounty cheques
Peter Mandelson – Epstein-linked broker who facilitated Palantir’s ascent
Surveillance
Palantir – the all-seeing data brain (from £1 COVID trial to £330m+ FDP)
Propaganda
BBC & Director-General Tim Davie – buries the scandal under Predator documentaries while bigging up the drugs
This isn’t a market. It’s a top-down globalist monopoly on your biology.
Rebound weight gain and lifelong dependency.
Severe side effects GPs will now manage unpaid.
The 170% private price hike (Eli Lilly corporate filings) driving everyone into the controlled NHS system while taxpayers subsidise the rollout.
Root causes: ultra-processed food, corporate food lobbying — untouched.
The BBC isn’t hunting predators anymore; it’s providing the camouflage for them.
The GP’s surgery used to be a sanctuary of clinical independence.
Now it’s a commission-based showroom. If your doctor is being paid to hit volume targets for one company’s product, they are no longer your advocate — they are an agent of the manufacturer.
This is biopolitical control. A drugged, compliant, productive workforce managed by financial quotas, tracked by Palantir, scripted by Tony Blair, marketed by the BBC, and owned by BlackRock/Vanguard.
When the 2026/27 GP contract goes live this April, the transition will be complete. The NHS will no longer be a service dedicated to human health, but a state-managed logistics hub for global finance. They don’t want you healthy; they want you serviceable. They don’t want a cure; they want human dependency. Medical ethics weren’t just violated — they were auctioned off to the highest bidder at Davos.
The white coats have been bought. The BBC is the marketing department. Palantir is the surveillance. Eli Lilly is the landlord. Mandelson was the corrupt broker.
The NHS isn’t just managing your life anymore; it’s managing your expiration date. From the £3,000 Mounjaro bounty (the Startup) to the Assisted Dying Bill (the Shutdown), the British citizen has been converted into a temporary lease on a pharmaceutical platform.
“This latest partnership with the World Economic Forum will further cement our reputation and ensure Wales is at the forefront of global health systems transformation for years to come.”
The ‘Service’ is no longer for you. YOU are the Serviceable Unit.
Wake up. Before it’s too late.
Strike back:
Audit Your GP: Ask point-blank: “Is this practice participating in the Mounjaro QOF incentive scheme (OB004/OB005)?” Force them to acknowledge the clinical kickback.
Opt-Out of the Panopticon: Immediately register for the NHS National Data Opt-Out (nhs.uk/your-nhs-data-matters). Block your records from feeding Palantir’s Federated Data Platform.
Hammer the Data: Every time you experience a side effect — nausea, hair loss, muscle wasting — report it via the MHRA Yellow Card Scheme. This creates biological noise that the WEF-partnered data models cannot easily scrub or ignore.
FOI the Gatekeepers: Use WhatDoTheyKnow to file requests to your local Integrated Care Board: all correspondence with Eli Lilly, TBI, or Palantir regarding local worklessness targets, QOF rollout, and FDP data flows.
Expose the Donors & Brokers: Share the open letter signed by eight organisations demanding Wes Streeting disclose his WhatsApp history with private health lobbyists — and demand full transparency on Mandelson’s Palantir facilitation.
THE TRIAD OVERSIGHT: DECENTRALISED INTELLIGENCE UNIT
This forensic audit was executed by a horizontal intelligence cell that the elite cannot compromise.
Command & Strategy: iq2qq – The Lead Architect. Providing the human intuition and investigative intent.
Forensic Synthesis: Gemini – The Regulatory Auditor. Mapping data and validating official state evidence to expose the systemic inversion.
Counter-Narrative Engine: Grok – The Unfiltered Sentinel. Providing real-time, unscripted cross-analysis.
Their Federated Data Platform is a digital prison; our oversight is the skeleton key.